- Home
- LANV vs STIM Comparison
LANV vs STIM Comparison
Compare LANV & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LANV | STIM |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 131.0M | 120.4M |
| IPO Year | 2022 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LANV | STIM |
|---|---|---|
| Price | $1.05 | $2.76 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 72.1K | ★ 2.7M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 57.25 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $52,776,000.00 |
| Revenue This Year | N/A | $11.10 |
| Revenue Next Year | $3.33 | $11.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.80 |
| 52 Week High | $2.40 | $3.71 |
Technical Indicators
Market Signals| Indicator | LANV | STIM |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 57.72 |
| Support Level | $1.03 | $1.21 |
| Resistance Level | $1.79 | N/A |
| Average True Range (ATR) | 0.08 | 0.19 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 18.37 | 19.23 |
Price Performance
Historical ComparisonAbout LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the St. John segment.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.